![Jake Bauer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jake Bauer
Director/Board Member at
IMMUNOVANT, INC.
Net worth: 5 M $ as of 31/05/2026
Profile
Jake Bauer is currently Chairman at Bridgebio Oncology Therapeutics, Inc. and Simcha Therapeutics, Inc. He is an Independent Director at Immunovant, Inc. and Attralus, Inc., Director at Simcha Therapeutics Holding Co. LLC and Enliven Therapeutics, Inc., Independent Director at Enliven Therapeutics, Inc., Venture Partner at ARCH Venture Partners LLC, SR One Capital Management LP, and GSK Equity Investments Ltd. Former roles include Director at Phoenix Tissue Repair, Inc., Independent Director at ARYA Sciences Acquisition Corp.
V and ARYA Sciences Acquisition Corp.
II, VP-Business Operations & Head-Development at Ablexis LLC, Chief Business Officer at MyoKardia, Inc., Consultant at Bristol Myers Squibb Co., Senior Associate and Principal at Third Rock Ventures LLC, Management Consultant at Putnam Associates LLC, and Principal at Zafgen, Inc., Global Blood Therapeutics, Inc., Royalty Pharma Cayman Partners LP, Endo Health Solutions, Inc., CytomX LLC, and Agios Pharmaceuticals, Inc. Education includes an undergraduate degree from Duke University and an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 87,372 ( 0.14% ) | 3 M $ | 31/05/2026 | |
IMMUNOVANT INC 0.02% | 07/04/2026 | 38,896 ( 0.02% ) | 1 M $ | 31/05/2026 |
-.--% | 16/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Jake Bauer active positions
| Companies | Position | Start |
|---|---|---|
| ENLIVEN THERAPEUTICS, INC. | Director/Board Member | 23/02/2023 |
| IMMUNOVANT, INC. | Director/Board Member | 01/04/2025 |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Simcha Therapeutics Holding Co. LLC
 Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Operates as a biotechnology company | Director/Board Member | - |
Simcha Therapeutics, Inc.
 Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for cancer | Chairman | 01/01/2022 |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | - |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 01/01/2021 |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Director/Board Member | 28/07/2021 |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Director/Board Member | 19/01/2022 |
Former positions of Jake Bauer
| Companies | Position | End |
|---|---|---|
| ░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Jake Bauer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
92
1st degree connections
25
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 25 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures analgesics pharmaceutical products | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Royalty Pharma Cayman Partners LP
 Royalty Pharma Cayman Partners LP Investment ManagersFinance Functions as a private equity fund | Finance |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Finance |
CytomX LLC
 CytomX LLC Medical SpecialtiesHealth Technology Develops protein therapeutics and integrated medical diagnostic devices | Health Technology |
Ablexis LLC
 Ablexis LLC Packaged SoftwareTechnology Services Develops next-generation platform for antibody drug discovery | Technology Services |
Putnam Associates LLC
 Putnam Associates LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic management healthcare consultancy services | Commercial Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Simcha Therapeutics Holding Co. LLC
Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Phoenix Tissue Repair, Inc.
 Phoenix Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Simcha Therapeutics, Inc.
Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for cancer | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
ARYA Sciences Acquisition Corp. II
 ARYA Sciences Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Health Technology |
ARYA Sciences Acquisition Corp. V
 ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Operates as a blank check company | Finance |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
- Stock Market
- Insiders
- Jake Bauer
